Investor Relations


<< Back
John W. Sharkey, Ph.D.
Executive Vice President, Business Development

John W. Sharkey, Ph.D. was appointed Executive Vice President in January 2010 after serving as VP of Business Development since November 2007. In his current role, Dr. Sharkey leads the group responsible for all activities related to identifying and assessing partnering opportunities, including mergers, acquisitions, licensing and divestments. Dr. Sharkey is an experienced healthcare professional having worked in both the pharmaceutical and medical device segments of the healthcare industry. He most recently served as the President of Ophthalmic International (OI), a device company focused on the non-surgical treatment of glaucoma. Prior to joining OI, Dr. Sharkey spent 16 years with Novartis Pharmaceuticals in increasing positions of responsibility on both the technical development and commercial sides of the business, eventually being appointed VP, BD&L for the Ophthalmic Business Unit. Dr. Sharkey earned a Ph.D. in Chemistry from the University of Buffalo and a B.S. in Chemistry from the State University College of New York at Oneonta.